chrX-2789673-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001141919.2(XG):āc.220C>Gā(p.Gln74Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000957 in 1,044,899 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001141919.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XG | NM_001141919.2 | c.220C>G | p.Gln74Glu | missense_variant | 5/11 | ENST00000644266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XG | ENST00000644266.2 | c.220C>G | p.Gln74Glu | missense_variant | 5/11 | NM_001141919.2 | |||
XG | ENST00000381174.10 | c.220C>G | p.Gln74Glu | missense_variant | 5/10 | 1 | P1 | ||
XG | ENST00000419513.7 | c.154C>G | p.Gln52Glu | missense_variant | 3/9 | 1 | |||
XG | ENST00000509484.3 | c.154C>G | p.Gln52Glu | missense_variant | 3/8 | 3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.57e-7 AC: 1AN: 1044899Hom.: 0 Cov.: 25 AF XY: 0.00000304 AC XY: 1AN XY: 329449
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.220C>G (p.Q74E) alteration is located in exon 5 (coding exon 5) of the XG gene. This alteration results from a C to G substitution at nucleotide position 220, causing the glutamine (Q) at amino acid position 74 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.